Laparoscopic Heller-Dor is an effective long-term treatment for end-stage achalasia
- PMID: 36217057
- PMCID: PMC10017584
- DOI: 10.1007/s00464-022-09696-8
Laparoscopic Heller-Dor is an effective long-term treatment for end-stage achalasia
Abstract
Background: The end-stage achalasia is a difficult condition to treat, for the esophageal diameter and conformation of the gullet, that may progress to a sigmoid shape. The aim of this study was to examine the outcome of Laparoscopic Heller-Dor in patients with end-stage achalasia, comparing them with patients who had mega-esophagus without a sigmoid shape.
Methods: From 1992 to 2020, patients with a diagnosis of sigmoid esophagus, or radiological stage IV achalasia (the SE group), and patients with a straight esophagus larger than 6 cm in diameter, or radiological stage III achalasia (the NSE group), were all treated with LHD. The two groups were compared in terms of patients' symptoms, based on the Eckardt score, and on barium swallow, endoscopy and manometry performed before and after the treatment. The failure of the treatment was defined as an Eckardt score > 3, or the need for further treatment.
Results: The study involved 164 patients: 73 in the SE group and 91 in the NSE group. No intra- or postoperative mortality was recorded. The median follow-up was 51 months (IQR 25-107). The outcome was satisfactory in 71.2% of patients in the SE group, and in 89% of those in the NSE group (p = 0.005).
Conclusions: SE is certainly the worst condition of the disease and the final outcome of LHD, in term of symptom control, is inferior compared to NSE. Despite this, almost 3/4 of the SE patients experienced a significant relieve in symptoms after LHD, which may therefore still be the first surgical option to offer to these patients, before considering esophagectomy.
Keywords: Achalasia; End-stage achalasia; Laparoscopic Heller-Dor; Sigmoid esophagus.
© 2022. The Author(s).
Conflict of interest statement
Renato Salvador, Giulia Nezi, Francesca Forattini, Federica Riccio, Arianna Vittori, Luca Provenzano, Giovanni Capovilla, Loredana Nicoletti, Lucia Moletta, Elisa Sefora Pierobon, Michele Valmasoni, Stefano Merigliano, Mario Costantini have no conflicts of interest or financial ties to disclose.
Figures




References
-
- Fox MR, Sweis R, Yadlapati R, Pandolfino J, Hani A, Defilippi C, Jan T, Rommel N. Chicago classification version 4.0© technical review: update on standard high-resolution manometry protocol for the assessment of esophageal motility. Neurogastroenterol Motil. 2021 doi: 10.1111/nmo.14120. - DOI - PMC - PubMed
-
- Oude Nijhuis RAB, Zaninotto G, Roman S, Boeckxstaens GE, Fockens P, Langendam MW, Plumb AA, Smout A, Targarona EM, Trukhmanov AS, Weusten B, Bredenoord AJ. European guideline on achalasia—UEG and ESNM recommendations. United Eur Gastroenterol J. 2020 doi: 10.1177/2050640620903213. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources